Citigroup’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.25M | Sell |
28,681
-52,391
| -65% | -$2.29M | ﹤0.01% | 2383 |
|
|
2025
Q1 | $2.22M | Buy |
81,072
+16,656
| +26% | +$456K | ﹤0.01% | 2001 |
|
|
2024
Q4 | $2.59M | Buy |
64,416
+29,852
| +86% | +$1.2M | ﹤0.01% | 1946 |
|
|
2024
Q3 | $1.64M | Buy |
34,564
+14,978
| +76% | +$709K | ﹤0.01% | 2192 |
|
|
2024
Q2 | $585K | Sell |
19,586
-201,325
| -91% | -$6.01M | ﹤0.01% | 2598 |
|
|
2024
Q1 | $8.88M | Buy |
220,911
+131,982
| +148% | +$5.31M | 0.01% | 950 |
|
|
2023
Q4 | $2.26M | Sell |
88,929
-11,867
| -12% | -$302K | ﹤0.01% | 1559 |
|
|
2023
Q3 | $1.4M | Sell |
100,796
-7,772
| -7% | -$108K | ﹤0.01% | 1696 |
|
|
2023
Q2 | $2.5M | Sell |
108,568
-96,163
| -47% | -$2.21M | ﹤0.01% | 1520 |
|
|
2023
Q1 | $6.07M | Buy |
204,731
+72,647
| +55% | +$2.15M | ﹤0.01% | 1033 |
|
|
2022
Q4 | $3.3M | Sell |
132,084
-68,956
| -34% | -$1.72M | ﹤0.01% | 1254 |
|
|
2022
Q3 | $4.38M | Buy |
201,040
+10,239
| +5% | +$223K | ﹤0.01% | 1180 |
|
|
2022
Q2 | $3.76M | Buy |
190,801
+169,002
| +775% | +$3.33M | ﹤0.01% | 1248 |
|
|
2022
Q1 | $923K | Sell |
21,799
-59,852
| -73% | -$2.53M | ﹤0.01% | 2421 |
|
|
2021
Q4 | $5.18M | Buy |
81,651
+28,313
| +53% | +$1.8M | ﹤0.01% | 1264 |
|
|
2021
Q3 | $3.13M | Sell |
53,338
-30,127
| -36% | -$1.77M | ﹤0.01% | 1569 |
|
|
2021
Q2 | $4.05M | Buy |
83,465
+19,780
| +31% | +$959K | ﹤0.01% | 1583 |
|
|
2021
Q1 | $2.48M | Buy |
63,685
+61,653
| +3,034% | +$2.4M | ﹤0.01% | 1814 |
|
|
2020
Q4 | $126K | Buy |
+2,032
| New | +$126K | ﹤0.01% | 3529 |
|